SERGIO ROMAN: Open Payments
NPI 1154994796 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,076 in 121 payments from 14 companies in 2025. Trend: 2023 $1,120 · 2024 $2,464 · 2025 $2,076
Food & beverage: $2,076
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $433 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 17 | $312 |
| Amgen Inc. | 13 | $230 |
| E.R. Squibb & Sons, L.L.C. | 27 | $220 |
| Novo Nordisk Inc | 2 | $156 |
| Esperion Therapeutics, Inc. | 10 | $142 |
| Merck Sharp & Dohme LLC | 6 | $126 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $125 |
| PFIZER INC. | 5 | $119 |
| CVRx, Inc. | 6 | $72 |
Products named: LEQVIO, JARDIANCE, REPATHA, CAMZYOS, Wegovy, NEXLETOL, Kerendia, ELIQUIS.
Industry payments across FL — which companies pay providers there.
